Publicacións en colaboración con investigadores/as de Hospital Duran i Reynals (9)

2023

  1. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

2022

  1. SEOM—GECOD clinical guideline for unknown primary cancer (2021)

    Clinical and Translational Oncology, Vol. 24, Núm. 4, pp. 681-692

2020

  1. Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

    World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85

  2. Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the American Academy of Dermatology, Vol. 83, Núm. 5, pp. 1535-1538

2019

  1. Quality indicators in radiation oncology: proposal of the Spanish Society of Radiation Oncology (SEOR) for a continuous improvement of the quality of care in oncology

    Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 519-533

2018

  1. Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

    Journal of Medical Imaging and Radiation Oncology, Vol. 62, Núm. 4, pp. 578-584

2017

  1. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma

    Oncotarget, Vol. 8, Núm. 18, pp. 30410-30421

2016

  1. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

    BMC Medicine, Vol. 14, Núm. 1

  2. SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)

    Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1213-1220